Falcon deep research report on lipl-4 (C. elegans)
-
LIPL-4 is a lysosomal acid lipase-like AB-hydrolase expressed prominently in the
intestine and localized to lysosomes via an N-terminal signal peptide, where it
shows acid pH-dependent triglyceride lipase activity that drives lysosome-derived
lipid signaling promoting longevity.
"**lipl-4** encodes **LIPL-4**, a **lysosomal acid lipase-like** enzyme expressed prominently in the **intestine** (major fat storage tissue) and localized to **lysosomes** via an N-terminal signal peptide. Experimentally, LIPL-4 shows **acid pH-dependent triglyceride lipase activity** and drives **lysosome-derived lipid signaling** that promotes longevity"
-
Lysosomal acid lipases including LIPL-4 release free fatty acids from
triacylglycerols and cholesteryl esters in intestinal lysosomes.
"Savini et al. describe lysosomal acid lipases (including LIPL-4) as releasing **free fatty acids** from **triacylglycerols (TAGs)** and **cholesteryl esters (CEs)**, situating LIPL-4 within TAG/CE lipolysis and FFA generation in intestinal lysosomes."
-
FLAG-tagged LIPL-4 co-localizes with the lysosomal marker LMP-1 in intestinal
cells, and its signal peptide is required for lysosomal targeting and for full
downstream signaling and longevity.
"FLAG-tagged LIPL-4 **co-localizes with the lysosomal marker LMP-1** in **intestinal cells**, indicating LIPL-4 is a lysosomal protein in vivo."
-
One pro-longevity arm of LIPL-4 signaling acts via the lipid chaperone LBP-8
and nuclear receptors NHR-49 and NHR-80, with OEA binding LBP-8 with about
3-fold higher affinity than other LIPL-4-associated lipids.
"LIPL-4-driven longevity requires **LBP-8** and the nuclear receptors **NHR-49** and **NHR-80**, consistent with a lysosome-generated lipid ligand being chaperoned to the nucleus to alter transcription."
-
The LIPL-4/LBP-8 axis links to mitochondrial physiology, increasing beta-oxidation,
raising mtROS, and activating JUN-1-dependent stress-response transcription that
improves oxidative stress tolerance and promotes longevity.
"LIPL-4 signaling also increases mitochondrial β-oxidation and mtROS/JUN-1 responses."
-
A second, intestine-to-neuron arm uses the secreted lipid chaperone LBP-3 binding
specific PUFAs (notably DGLA) and acting through neuronal NHR-49 and the
neuropeptide NLP-11 to promote longevity.
"A secreted lipid chaperone, **LBP-3**, binds specific PUFAs and is required for LIPL-4-induced neuronal changes and longevity."
-
Intestinal LIPL-4 signaling induces neuronal neuropeptide signaling dependent on
neuronal NHR-49 and the neuropeptide NLP-11, with DGLA highlighted as a key
PUFA mediator.
"Intestinal LIPL-4 signaling induces neuronal **neuropeptide signaling**; functional experiments show dependence on neuronal **NHR-49** and neuropeptide **NLP-11**."
-
2024 lysosome immunopurification proteomics shows lipl-4 transgenic worms have
extensive lysosome proteome remodeling (449 lysosome-enriched proteins, only 39%
overlap with WT) and perinuclear lysosome clustering in intestinal cells.
"**449 lysosome-enriched proteins** identified in lipl-4 Tg, with only **39% overlap** vs WT lysosome-enriched proteins; **61%** of proteins enriched on lipl-4 Tg lysosomes were absent from WT lysosomes."
-
lipl-4 transgenic longevity depends on nuclear import machinery (npp-6 nucleoporin,
ima-3 importin-alpha) and lysosome-associated AMPK; impairing AMPK reduces the
lipl-4 Tg lifespan extension from 72% to 48%.
"reduces lipl-4 Tg extension from **72% to 48%**."